- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04401722
Clinical Impact of Altitude Level on Surgical Outcomes of Pancreaticoduodenectomy (PD)
June 6, 2020 updated by: Ayman El Nakeeb, Mansoura University
Clinical Impact of Altitude Level on Surgical Outcomes of Pancreaticoduodenectomy for Periampullary Tumour (Multicenter Study)
Very few papers examine the effect of living at high altitudes on surgical results of major operations.
This research is designed to determine the surgical outcomes of PD for periampullary tumour in high altitudes and normal altitudes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Many recent studies have suggested multiple risk factors affecting postoperative surgical outcomes of PD; THE research is designed to determine the surgical outcomes of PD for periampullary tumour in high altitudes and normal altitude.
it is a multicenter study Aseer central hospital, Saudia and from Egypt two centers Mansoura university and el Menia university
Study Type
Interventional
Enrollment (Actual)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Mansoura, Egypt, 356111
- Mahmoud Abd El Wahab
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- periampulary tumour
Exclusion Criteria:
- liver cirrhosis,
- PG,
- advanced tumour,
- vascular resection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: PD in normal altitude
PD underwent in the area at the level of the sea, normal altitude region
|
dissection and removal of periampulary tumour with 3 reconstruction PJ, HJ, and GJ
Other Names:
|
Active Comparator: PD in high altitude region.
PD underwent in high altitude region.
|
dissection and removal of periampulary tumour with 3 reconstruction PJ, HJ, and GJ
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the overall postoperative complications
Time Frame: 30 DAYS
|
the overall postoperative complications
|
30 DAYS
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
blood loss
Time Frame: INTRAOPERATIVE
|
blood loss
|
INTRAOPERATIVE
|
Pulmonary embolism (PE)
Time Frame: 30 days
|
Pulmonary embolism (PE)
|
30 days
|
hospital mortality
Time Frame: 30 days
|
death within 30 days of operation
|
30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ayman E Nakeeb, MD, Mansoura University, Gastrointestinal Surgery Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Dutta V, Singh R, Kumar S, Aggarwal N, Hari Kumar KVS. Profile of pulmonary embolism in service personnel posted at high altitude area. Indian Heart J. 2018 May-Jun;70(3):427-429. doi: 10.1016/j.ihj.2017.08.002. Epub 2017 Aug 18.
- El Nakeeb A, Attia M, El Sorogy M, Ezzat H, Shehta A, Salem A, El Gawad MA, Hamed H, Allah TA, El-Geidi AA, Fathy O, El Hefnawy E, Zaghloul A. Laparoscopic Pancreaticodudenectomy for Periampullary Tumor: Should it be a Routine? A Propensity Score-matched Study. Surg Laparosc Endosc Percutan Tech. 2020 Feb;30(1):7-13. doi: 10.1097/SLE.0000000000000715.
- El Nakeeb A, El Sorogy M, Hamed H, Said R, Elrefai M, Ezzat H, Askar W, Elsabbagh AM. Biliary leakage following pancreaticoduodenectomy: Prevalence, risk factors and management. Hepatobiliary Pancreat Dis Int. 2019 Feb;18(1):67-72. doi: 10.1016/j.hbpd.2018.10.005. Epub 2018 Oct 28.
- Prabhakar A, Chatterjee T, Bajaj N, Tyagi T, Sahu A, Gupta N, Kumari B, Nair V, Kumar B, Ashraf MZ. Venous thrombosis at altitude presents with distinct biochemical profiles: a comparative study from the Himalayas to the plains. Blood Adv. 2019 Nov 26;3(22):3713-3723. doi: 10.1182/bloodadvances.2018024554.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2018
Primary Completion (Actual)
April 1, 2020
Study Completion (Actual)
April 25, 2020
Study Registration Dates
First Submitted
May 21, 2020
First Submitted That Met QC Criteria
May 22, 2020
First Posted (Actual)
May 26, 2020
Study Record Updates
Last Update Posted (Actual)
June 9, 2020
Last Update Submitted That Met QC Criteria
June 6, 2020
Last Verified
June 1, 2020
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- PD in high altitude
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
it will be available for other researchers
IPD Sharing Time Frame
6 month
IPD Sharing Access Criteria
elnakeebayman@yahoo.com
IPD Sharing Supporting Information Type
- Study Protocol
Study Data/Documents
-
Study Protocol
Information identifier: Ayman El NakeebInformation comments: through elnakeebayman@yahoo.com
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Periampullary Cancer
-
Yonsei UniversityUnknown
-
Lund UniversityRecruitingPancreatic Cancer | Periampullary Cancer | Periampullary AdenocarcinomaSweden
-
Asan Medical CenterSamsung Medical Center; Seoul National University Bundang Hospital; Severance... and other collaboratorsCompletedPeriampullary Cancer | Laparoscopy | Functional RecoveryKorea, Republic of
-
University of AlexandriaCompletedPeriampullary Cancer | Biliary Obstruction | Preoperative Biliary Drainage
-
Seoul National University HospitalBoston Scientific CorporationCompletedPeriampullary Cancer | JaundiceKorea, Republic of
-
Asan Medical CenterCompleted
-
Indiana UniversityCompletedPeriampullary NeoplasmsUnited States
-
Case Comprehensive Cancer CenterRecruitingPeriampullary Cancer | Pancreatic Ductal AdenocarcinomaUnited States
-
Southwest Hospital, ChinaUnknownPancreatic Cancer | Periampullary CarcinomaChina
-
Asan Medical CenterNot yet recruitingPeriampullary Cancer | Borderline Malignancy TumorKorea, Republic of